Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper

Chimeric antigen receptor (CAR) T-cell therapy is one of the most promising emerging treatments for B-cell malignancies. Recently, two CAR T-cell products (axicabtagene ciloleucel and tisagenlecleucel) have been approved for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia;...

Descripción completa

Detalles Bibliográficos
Autores principales: Los-Arcos, Ibai, Iacoboni, Gloria, Aguilar-Guisado, Manuela, Alsina-Manrique, Laia, Díaz de Heredia, Cristina, Fortuny-Guasch, Claudia, García-Cadenas, Irene, García-Vidal, Carolina, González-Vicent, Marta, Hernani, Rafael, Kwon, Mi, Machado, Marina, Martínez-Gómez, Xavier, Maldonado, Valentín Ortiz, Pla, Carolina Pinto, Piñana, José Luis, Pomar, Virginia, Reguera-Ortega, Juan Luis, Salavert, Miguel, Soler-Palacín, Pere, Vázquez-López, Lourdes, Barba, Pere, Ruiz-Camps, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518951/
https://www.ncbi.nlm.nih.gov/pubmed/32979154
http://dx.doi.org/10.1007/s15010-020-01521-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518951/
https://www.ncbi.nlm.nih.gov/pubmed/32979154
http://dx.doi.org/10.1007/s15010-020-01521-5

Ejemplares similares